AbCellera Biologics Statistics
NASDAQ: ABCLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
12.83-0.32 (-2.43%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 12.98 +1.17%
AbCellera Biologics by the numbers
AbCellera Biologics has a market capitalization of $4.16 billion based on 324.05M shares outstanding. With trailing EPS of $-0.54, AbCellera Biologics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.1% above its 50-day average and 110.9% above its 200-day average.
Average daily trading volume is 6.74M shares, or about $86.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ABCL valuation vs. peer median
| Metric | ABCL | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.16B | $4.02B | +3% |
| Avg. volume | 6.74M | 1.72M | +293% |
Peer median across 8 companies: INDV, EWTX, MANE, TLX, DNTH, LEGN, TNGX, VKTX.
Valuation
- Market cap
- $4.16B
- Price / sales (latest FY)
- 55.34
- EPS (TTM)
- $-0.54
- Shares outstanding
- 324.05M
Price and trading
- Previous close
- 13.15
- Open
- 12.85
- Day range
- 12.56 – 13.45
- 52-week range
- 2.75 – 15.02
- 52-week change
- +122.96%
- Beta
- —
- Volume
- 5.00M
- Average volume
- 6.74M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 4.16B
- Forward Pe
- -16.45
- Eps
- -0.54
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 15.02
- Week52 Low
- 2.75
- Avg Volume
- 6.74M
- Shares Outstanding
- 324.05M
- Ma50
- 10.86
- Ma200
- 6.08
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -14.55%
- Pct From52w Low
- 367.40%